The fusogenic properties of the uncleaved spike (S) protein of murine coronavirus JHMV variant cl-2 were studied by expressing the S protein with a deleted putative cleavage site. The amino acid sequence of the putative cleavage site, Arg-Arg-Ala-Arg-Arg, was replaced by Arg-Thr-Ala-Leu-Glu by in vitro mutagenesis of the cl-2 S protein cDNA. Recombinant vaccinia viruses containing the cl-2 S cDNA [RW t(+)] or the mutated cDNA [RW t(-)] were constructed and monitored for fusion formation and cleavage of the expressed S proteins. When cultured DBT cells were infected with RW t(+) at a multiplicity of infection of 0.5, fusion formation was first observed at 10 to 12 h postinoculation and spread throughout the whole culture by 20 to 24 h postinoculation. In cells infected with RW t (-) results concerning the fusion formation and cleavage properties of the S proteins were reproduced by the transiently expressed S proteins. These results suggest that the cleavage event in the S protein of murine coronavirus JHMV is not a prerequisite for fusion formation but that it does facilitate fusion formation.
expressing the wild-type S protein and the mutated S protein. However, interestingly, the cleavage products of the S protein, Si and S2, were not detected in RW t(-)-infected cells, producing the mutated S protein, even though fusion was clearly visible. Both products were, of course, detected in RW t(+)-infected DBT cells, producing the wild-type S protein. The same results concerning the fusion formation and cleavage properties of the S proteins were reproduced by the transiently expressed S proteins. These results suggest that the cleavage event in the S protein of murine coronavirus JHMV is not a prerequisite for fusion formation but that it does facilitate fusion formation.
Coronaviruses are enveloped viruses with single-stranded, positive-sense genomic RNA that is 26 to 31 kb in length (15, 29) . They are important respiratory, neurologic, and enteric pathogens for humans and domestic animals. The virions, 60 to 170 nm in size, contain two species of transmembrane glycoprotein, the spike (S) protein and the integral membrane (M) protein. In some coronaviruses, a third membrane glycoprotein, the hemagglutinin-esterase (HE) protein, is also found. Inside the virion envelope is the nucleocapsid, which is composed of genomic RNA and multiple monomers of the nucleocapsid (N) protein (28, 29) .
The S protein, comprising the peplomer on the virion surface, is 150 to 180 kDa, depending on the virus (21, 28, 29, 32) . This protein is multifunctional (6, 11, 28, 29) . It is known that the S protein is involved in an initial step of virus infection by binding to the receptor on susceptible cells (5, 41) . Fusion of infected cells into polykaryocytes has also been shown to be dependent on the S protein (1, 29, 36, 37) . In addition, the major neutralizing epitopes exist on the S protein, and it is recognized by cytotoxic lymphocytes (13) . Furthermore, speculation is that the S protein is, if not totally, at least mostly involved in the virulence of the virus (2, 6, 7, 19, 38) . However, correlation of these biological activities with the S protein structure has not been clarified, except for some neutralizing epitopes (17, 23) .
Fusion formation occurs in cells infected with orthmyxoviruses (14, 40) , paramyxoviruses (12, 24) , retroviruses (16, 20) , and other enveloped RNA viruses (40) . In these viruses, glycoproteins protruding from the envelope are responsible for fusion activity (40) . These glycoproteins on the virion surface are cleaved by a host cell-derived proteolytic enzyme that activates the fusogenic potential of the proteins (12, 16, 40) . Proteolytic cleavage of the proteins places the hydrophobic amino acid cluster at the N terminus of the membrane-anchoring chain of the cleavage product (40) . The hydrophobic amino acid cluster is designated the fusion peptide and may work as the fusion active site (40) .
Cells infected with murine coronaviruses are usually fused (28, 29) , and it is clear that the S protein is not only important but also sufficient for fusion formation, since the S protein expressed by various vectors can induce fusion formation (10, 33, 36) . In addition, it has been reported that a cleavage event is also important for the manifestation of the fusogenic properties of the S protein (8, 30, 31) , as in the cases of orthomyxoviruses and paramyxoviruses (40) . Cleavage of the S protein is supposed to be carried out by a host cell-derived trypsin-like proteolytic enzyme. In the case of murine coronavirus JHMV, the putative cleavage site is composed of the basic amino acid cluster Arg-Arg-Ala-ArgArg (22, 25, 33) . On the other hand, it has been reported that cleavage product S2 has no hydrophobic amino acid cluster that might function as a putative fusion peptide (22, 25, 29, 33) . This situation differs from those of other viruses with fusion activity (40) . This finding suggests that the mechanisms of coronavirus fusion formation may be different from those of the orthomyxoviruses and paramyxoviruses. For delineation of the coronavirus fusion mechanism, it is important to determine whether S protein cleavage is required for S protein fusion formation.
In this report, fusion formation by cleaved and uncleaved S proteins, expressed in mouse DBT cells by recombinant vaccinia viruses (RVVs) or in a transient expression system, was studied. The results suggested that cleavage of the S protein is not a prerequisite for fusion formation but that it does somehow enhance or facilitate fusion formation. Cla  GTCA CGC AGA GCC CGC CGA TCA GTT TCTACTGGCTATCGATTAACCACA   C-----T--A---------------------------_______   R   T  A  L  E  S V   3' CAGT GCG TGT CGG GAG GTT AGT CAA AGATGACCGATAGCTAATTGGTGT Oligonucleotide-directed site-specific mutagenesis and preparation of RVWs. The cDNA of the cl-2 S gene, obtained as previously reported (33) , was used as a target for sitespecific mutagenesis by use of the polymerase chain reaction (PCR). To replace the nucleotide sequence for the putative cleavage site, Arg-Arg-Ala-Arg-Arg, we prepared by using a gene assembler (Pharmacia) a 49-mer synthetic oligonucleotide, JHM-Try(-), 5 'TGTGGTTAATCGATAGCCAGTAG AAACTGATTGGAGGGCTGTGCGTGAC3', which is complementary to the genome sense. JHM-Try(-) has a nucleotide sequence that encodes Arg-Thr-Ala-Leu-Glu in place of the putative cleavage site and that has a ClaI site at the 5' end ( Fig. 1) . Another oligonucleotide, the complement of JHM-Try(-) in PCR, was S-P (1592), 5'TACACGTGT GAGTGCACTTG3', which is genomic sense and corresponds to the nucleotide sequence from 1592 to 1611, located about 650 nucleotides upstream from the region of the JHM-Try(-) sequence. After amplification with this pair of primers and cl-2 S cDNA as a template, the fragment was cut with ClaI and BalI, and the resulting 443-nucleotide fragment was inserted into pUC19 containing cl-2 S cDNA (pUC19-c12S) with a deletion of the Clal-Ball fragment. The cDNA with the mutated fragment, pUC19-c12S-t(-), was selected by hybridization with oligonucleotide t(-) 20m, 5'AAACTGATTGGAGGGCTGTG3', which specifically bound to the mutated sequence, and finally confirmed by nucleotide sequencing by dideoxynucleotide chain termination. pUC19-c12S-t(-) was then cut with BamHI, and cl2S-t(-) was isolated and treated with T4 DNA polymerase to yield blunt ends. The blunt-ended fragment was inserted into transfer vector pSF7.5EB1-B5-12 (pSF) (9), provided by H.
Shida, and cut with SmaI to make RWs. An RW with cl-2 S cDNA containing the putative cleavage site, RVV t(+) (33) , and that with mutated S cDNA, RVV t(-), were prepared as previously reported (9, 33) . The nucleotide sequence of the putative cleavage site of RVV t(+) and the mutated site of RVV t(-) were amplified by PCR with a pair of primers, P8, 5'ATlTlCCCGTGAGGAAAAACCC3', which corresponded to nucleotides 2162 to 2181, and S-N (2460), 5'CACC(TlGGG GAGCCC(TIATC3', which corresponded to the negativesense nucleotide sequence from 2479 to 2460. These were prepared on the basis of registered sequence data (33) . The fragments were inserted into pUC19, and the areas around the putative cleavage sites were sequenced.
Transient expression. DBT Immunoprecipitation. DBT cells were infected with RVV t(+), RVV t(-), or VV-HA(-) at an MOI of 0.3 to 0.5 and incubated for 14 h. The medium was then changed to Dulbecco's modified minimal essential medium without methionine, and the culture was incubated for 30 min (27, 34 (Fig. 2) , except for a 2-to 4-h delay in appearance and development. This result is clearly shown in a comparison of RVV t(-) and RVV t(+) kinetics of fusion formation in Fig.  3 . The fusion produced by RW t(+) and RVV t(-) was due to S protein expression, on the basis of the fact that fusion formation was prevented by MAbs specific for the cl-2 S protein (data not shown). Moreover, the fused cells were revealed to express S proteins by immunofluorescence. These data clearly showed that the wild-type S protein as well as the mutated S protein containing Arg-Thr-Ala-LeuGlu in place of Arg-Arg-Ala-Arg-Arg induced fusion in DBT cells.
Fusion was observed previously in some cell lines infected with VV-HA(-) (26) . This result suggests that the fusion observed in DBT cells infected with RWs was due to the intrinsic fusion activity of VV-HA(-) and not to the fusogenic properties of the S protein, because all of the RVVs had been selected on the basis of the HA-negative phenotype (9, 33) . However, fusion was hardly detectable in DBT cells infected with VV-HA(-). For exclusion of the possibility that VV-HA(-) influences fusion, S proteins were transiently expressed by the transfection of pSFt(+) or pSFt(-) together with infection by VV-HA(+). DBT cells were infected with VV-HA(+) at an MOI of 0.5, and at 10 h p.i., the cells were transfected with pSFt(+) or pSFt(-). Thereafter, fusion formation was checked every 6 h for 24 h. In this system, DBT cells producing the wild-type S protein as well as those producing the mutated S protein were shown to be fused. This fusion was the same as that during RVV infection; fusion by the wild-type S protein was first observed at about 6 h posttransfection, while that by the mutated S protein was detected at 8 to 9 h posttransfection. The appearance and development of fusion by the expressed, mutated S protein was delayed 3 to 4 h compared with that by the wild-type S protein (Fig. 4) .
Analysis The S protein and its cleavage products were also examined in a transient expression system (Fig. 7) . As was observed in the infection with RVVs, cleavage of the S protein was detected in cells producing the wild-type S protein but not in cells expressing the mutated S protein.
These results indicated that the mutated S protein was much more resistant to proteolytic cleavage by host cell-derived enzymatic activity than the wild-type S protein, with its predicted cleavage site.
DISCUSSION
Fusion formation observed in cells infected with murine and other coronaviruses (28, 29) is mediated by the S protein, as evidenced by the facts that S protein-specific MAbs are capable of inhibiting fusion formation (1, 37) and that the expression of the S protein in the absence of other virus-related proteins is able to induce fusion formation (10, 33, 36) . The cleavage event has been suggested to be an important step for fusion formation, as indicated by experiments in which mouse hepatitis virus, with a fusion-negative phenotype, was rendered capable of fusion after treatment with proteolytic enzymes (30, 31, 42) . Also, it has been reported that a correlation exists between the degree of cleavage of the S protein and the extent of fusion in different virus-cell systems (8) . All of these data suggest that cleavage of the S protein is a prerequisite for fusion formation by the (12, 24) , orthomyxoviruses (14, 40) , and retroviruses (16, 20) . The 5) , RVV t(+) (lanes 2 and 6), and RVV t(-) (lanes 3 and 7), or VV-HA(-) (lanes 4 and 8) . The lysates were denatured without DTT in sample buffer at room temperature for 3 min. After SDS-polyacrylamide gel electrophoresis in a 10% polyacrylamide gel, the proteins were transferred to a nitrocellulose membrane and the S proteins were detected with MAb 8, specific for Si (lanes 1, 2, 3, and 4), or 10G, specific for S2 (lanes 5, 6, 7, and 8).
showed that fusion formation occurred in the presence of uncleaved S protein containing a mutation in the putative cleavage site. This result implied that cleavage of the S protein was not a prerequisite for the fusogenic activity of the S protein. However, the possibility that trace amounts of the S protein undetectable even by Western blotting are responsible for fusion activity cannot completely be excluded. The data also showed that cleavage of the S protein enhanced fusion formation by the S protein. different from those of proteins of other fusogenic RNA viruses, an idea that has been proposed because the hydrophobic amino acid cluster, designated the fusion peptide in other fusogenic RNA viruses (40) , is not found at the N terminus of the membrane-anchoring chain of coronavirus S protein cleavage product S2 (10, 22, 25, 29, 33) . Semliki forest virus and Sindbis virus, each capable of inducing fusion in infected cells after cleavage of the envelope protein, are known to lack the putative fusion peptide at the N terminus of the membrane-anchoring chain but internally have a putative fusion peptide composed of 16 to 17 hydrophobic amino acids (40) . However, such a large stretch of hydrophobic amino acids does not exist in the S protein of JHMV variant cl-2 (33) or in the S proteins of other coronaviruses (10, 22, 25, 29) . Sequence analysis has shown that some other coronaviruses, i.e., feline infectious peritonitis virus and porcine transmissible gastroenteritis virus, do not have the predicted proteolytic cleavage site on the S protein (3, 29). Nevertheless, fusion was found in cells infected with such viruses (4, 36) . All of these facts, together with the present findings, suggest that the mechanisms of fusion induced by coronaviruses must be distinct from those of other fusogenic RNA viruses.
Little is known about the mechanism of fusion formation by coronavirus S protein, and there are only a few reports analyzing the relationship between the structure and fusion formation by the S protein in murine coronaviruses (17, 23) . It has been reported that in fusion-negative mutant viruses, the hydrophobic domain located within the S2 heptad repeat is associated with pH-dependent fusion formation (10) . Because MAbs specific for both the S1 and the S2 subunits prevent fusion formation, it has been suggested that these subunits are important for fusion formation (39) . More precisely, it is assumed that two different domains are involved, the N terminus of the S1 subunit and the domain near the heptad repeat in the S2 subunit (23) . Also, a region about 130 amino acids from the N terminus of the S2 subunit is likely to be involved in fusion formation, as suggested by MAb mapping (1, 17) . Study of the MAbs isolated in our laboratory revealed that MAbs recognizing highly conformational epitopes, i.e., epitopes destroyed even by mild denaturation, had high fusion-inhibiting activity (unpublished data), which would indicate that a secondary or tertiary structure of the S protein may be important for fusion activity. As for the structure of the fusion active site, both the S1 and the S2 subunits may be involved, as discussed by Routledge et al. (23) . That MAbs against different epitopes
